Content about Pharmacy

February 4, 2008

Roche Holding’s chief executive officer Franz Humer stepped down from his position yesterday, turning over...

February 4, 2008

Studies have been taken place for decades to find ways to combat Alzheimer’s disease, but...

February 3, 2008

Over the weekend, the AIDS Healthcare Foundation opened its newest AHF Pharmacy in West Hollywood,...

February 3, 2008

AstraZeneca recently reported its fourth quarter and full year results. Profits for the company in...

February 3, 2008

The Food and Drug Administration has approved Schering-Plough’s asthma inhaler Asmanex twisthaler 110 mcg for...

February 3, 2008

The Food and Drug Administration has released its proposed budget for fiscal 2009 from the...

February 3, 2008

The Food and Drug Administration has stated that Eli Lilly’s schizophrenia drug, Zyprexa, when taken...

February 3, 2008

The U.S. Attorney’s Office in Boston has notified Biovail that it is the target of...

February 3, 2008

The Federal Trade Commission is arguing that if a ruling upholding a 1997 settlement between...

February 3, 2008

PsychoGenics and Eli Lilly have entered into a drug discovery agreement aimed at identifying drug...

February 3, 2008

According to published reports, a group of Maryland lawmakers have formed a biotechnology and life...

February 3, 2008

The independent pharmacy industry’s chief advocacy group is hailing the Bush administration’s new campaign to...

February 3, 2008

Roche is asking a U.S. judge for clearance to sell an anti-anemia drug by offering...

February 3, 2008

Teva has decided not to sell a generic version of the acid reflux drug Protonix,...

February 2, 2008

A new report published in the March issue of the American Journal for Psychiatry states...

January 31, 2008

It’s apparent that the pharmaceutical landscape continues to be dominated by major brand-name drugs losing patent protection and a flurry of generic launches aimed at taking whatever share of the market they can. That’s good news and bad news for pharmacy retailers; good in that the generic introductions are expected to drive huge profit gains during their initial 180-day exclusivity period, bad in that prices tend to fall away quite dramatically in the period thereafter due to the increased competition that results, depressing top-line sales growth.

January 31, 2008

Mylan has received approval from the Food and Drug Administration for its application for a...

January 31, 2008

Aurobindo Pharma has received tentative approval from the Food and Drug Administration to market and...

January 31, 2008

Labopharm’s appeal of a second approvable letter from the Food and Drug Administration for a...

January 31, 2008

The Food and Drug Administration has released information stating that there is an increased risk...

January 31, 2008

Hologic and KV Pharmaceuticals have signed an agreement under which Hologic will sell full rights...

January 31, 2008

The U.S. Attorney’s Office for the District of Massachusetts is investigating Merck over the promotion...

January 31, 2008

Schering-Plough has signed a sponsorship deal with NASCAR star Carl Edwards, under which the company’s...

January 31, 2008

A peer reviewer for The New England Journal of Medicine broke confidentiality by leaking a...

© 2013 Drug Store News. All Rights Reserved.